Could we spot misinformation while there’s still time to respond? During the Irkutsk episode, PROACT EU-Response partners adapted an early monitoring tool to track plague-related messages. It identified six narratives within days, showing how monitoring can help detect weak signals.

What should trials for flu, COVID-19 and RSV measure? Help PROACT EU-Response define a core outcome set. Patients, carers, regulators and policymakers: take our survey by 31 October. It takes 20 minutes to complete. www.calibrum.net/srvcas3/w.as...

🔦 #PartnerSpotlight: Meet @eupatientsforum.bsky.social, a PROACT EU-Response partner bringing the patient perspective into pandemic preparedness and clinical research. EPF supports patient involvement across the project, including through our Patient Advisory Group.

EU-SyndAct combines an innovative platform trial design with patient involvement, looking beyond clinical outcomes to include symptoms, quality of life and patients’ experiences. 🔗 Read more: proact-response.eu/eu-syndact-a... #PROACTEUResponse #ClinicalTrials

PROACT EU-Response’s Patient Advisory Group provides continuous patient input across the project, helping ensure research reflects patients’ needs, priorities and lived experiences, from trial design to preparedness planning. 🤝 Meet the PAG: proact-response.eu/consortium/p...

PROACT EU-Response’s Scientific and Ethics Advisory Board provides independent expertise to guide the project’s research, trial strategy and governance and help prepare Europe for future health emergencies. Meet the SEAB 👇 proact-response.eu/scientific-a... #ResearchEthics

I really enjoyed #CADS2026 last week! So many fascinating presentations on how we can analyse large datasets of discourse with corpus methods! I presented our analysis conducted for @proacteuresponse.bsky.social, which looked at the ways users discussed clinical trial studies during the pandemic.

What happens after a health emergency ends? For PROACT EU-Response, the answer is clear: we build on what we've learned. 🎥 Hear Coordinator Prof. Karine Lacombe explain how the project is strengthening Europe's preparedness. 🔗 proact-response.eu/about #PROACTEUResponse #PandemicPreparedness

Last week, the PROACT EU-Response consortium gathered in Brussels for its Annual Meeting.

🦠 Preparedness starts before the next outbreak. Today, PROACT EU-Response partners meet in Brussels to strengthen Europe's readiness for future infectious disease threats through collaboration, research, and innovation. #PandemicPreparedness #ClinicalResearch #PublicHealth

🌍 Europe is moving from crisis response to pandemic preparedness. What started during COVID-19 with EU-RESPONSE is now evolving into PROACT EU-Response — a long-term effort to help Europe prepare for future health threats. 📖 Read more: bit.ly/4uHlXGs

As the world follows the recent hantavirus outbreak linked to the MV Hondius cruise ship, it is a reminder that infectious threats can escalate quickly across borders. PROACT EU-Response is helping strengthen Europe’s readiness for future outbreaks.

It’s World Immunization Week! Vaccines protect people across generations, preventing millions of deaths every year. At PROACT EU-Response, we support this through: 🔬 Clinical trials 🧪 Immunology networks 📊 Better data for faster responses 🔗 proact-response.eu #VaccinesWork #WorldImmunizationWeek

Today is International Fact-Checking Day. Reliable information is key in health crises: it builds trust, supports evidence-based decisions, and strengthens preparedness. Tackling misinformation and building trust in health authorities are essential to effective response. #FactsFirst

Not sure if a health claim online is reliable? A few simple checks can help: 🔎 Who’s the source? Is it a trusted authority? 🗓️ When was it published? Is it up to date? 📊 What’s the evidence? Do other credible sources confirm it?

Can you spot misinformation during a health crisis? 👀 False claims about treatments or vaccines can spread faster than verified information, creating confusion and slowing response efforts.

Randomised trials are fundamental to evidence-based healthcare. This free FutureLearn course, developed with the University of Galway (a PROACT EU-RESPONSE partner), explains their role in modern clinical research. www.futurelearn.com/courses/rand... #ClinicalTrials #EUResearch

Looking back to November: Prof. Karine Lacombe spoke at the 9th Trials Methodology Symposium in Cork about the importance of pragmatism in pandemic preparedness, especially the need for flexibility, rapid adaptation and evidence-based decisions.

Last week, our project is featured at #EPFCongress2025. Great insights from: • Prof. Karine Lacombe – Plenary 1 • Mélanie Host – Workshop 4 We also presented our poster on how patient engagement + social science strengthen PROACT EU-RESPONSE. Better trials start with patients. 💙

The PROACT EU-Response was presented to the EMA Emergency Task Force, highlighting how adaptive, pan-European clinical trials like EU-SyndAct strengthen Europe’s capacity to respond to COVID-19, RSV, and influenza. 🔗 proact-eu-response.eu

We’re proud to announce that PROACT EU-Response will be showcased at #EPFCongress2025 (26–27 Nov, Brussels)! Two days of dialogue on patient involvement, equity, resilience, digital health, AMR, and climate & health. 👉 epfcongress.eu #PatientLeadership

We are seeking patient representatives to join the Patient Advisory Group (PAG) for the PROACT EU-Response project, which aims to boost Europe’s preparedness for future pandemics through a network of adaptive clinical trials. 💡Learn more and apply: bit.ly/45ilYXg